Posted by Michael Wonder on 22 Feb 2023
MSAC publishes agenda for June 2023 ESC meeting
22 February 2023 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC on 8 -9 June 2023.
The agenda currently has 8 items. Applications of note include:
- 1657 – Rhenium Re 188 brachytherapy for non-melanoma skin cancer
- 1686.1 – Lutetium Lu 177 PSMA for metastatic castrate resistant prostate cancer
- 1732 – Imlifidase as a desensitisation treatment to enable kidney transplant in highly sensitised adult transplant candidates
- 1748 – Review of tisagenlecleucel for treatment of confirmed relapsed/refractory CD19 positive acute lymphoblastic leukaemia in children and young adults up to 25 years old
